Credit Suisse’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,100
| Closed | -$97K | – | 3193 |
|
|
2023
Q1 | $97K | Hold |
23,100
| – | – | ﹤0.01% | 3192 |
|
|
2022
Q4 | $64K | Buy |
+23,100
| New | +$64K | ﹤0.01% | 3368 |
|
|
2022
Q3 | – | Sell |
-21
| Closed | – | – | 4114 |
|
|
2022
Q2 | $0 | Buy |
+21
| New | – | ﹤0.01% | 4065 |
|
|
2021
Q1 | – | Sell |
-10,914
| Closed | -$47K | – | 3460 |
|
|
2020
Q4 | $47K | Buy |
+10,914
| New | +$47K | ﹤0.01% | 3403 |
|
|
2016
Q3 | – | Sell |
-60,635
| Closed | -$173K | – | 3773 |
|
|
2016
Q2 | $173K | Buy |
+60,635
| New | +$173K | ﹤0.01% | 3611 |
|
|
2016
Q1 | – | Sell |
-10,467
| Closed | -$37K | – | 3767 |
|
|
2015
Q4 | $37K | Buy |
10,467
+87
| +0.8% | +$308 | ﹤0.01% | 3920 |
|
|
2015
Q3 | $39K | Sell |
10,380
-299
| -3% | -$1.12K | ﹤0.01% | 3970 |
|
|
2015
Q2 | $61K | Sell |
10,679
-42,951
| -80% | -$245K | ﹤0.01% | 4145 |
|
|
2015
Q1 | $312K | Buy |
53,630
+25,664
| +92% | +$149K | ﹤0.01% | 3569 |
|
|
2014
Q4 | $159K | Buy |
+27,966
| New | +$159K | ﹤0.01% | 3960 |
|
|
2014
Q3 | – | Sell |
-57,117
| Closed | -$260K | – | 4082 |
|
|
2014
Q2 | $260K | Buy |
57,117
+14,358
| +34% | +$65.4K | ﹤0.01% | 3777 |
|
|
2014
Q1 | $203K | Buy |
42,759
+9,134
| +27% | +$43.4K | ﹤0.01% | 3972 |
|
|
2013
Q4 | $158K | Buy |
33,625
+1,560
| +5% | +$7.33K | ﹤0.01% | 3936 |
|
|
2013
Q3 | $127K | Buy |
32,065
+8,055
| +34% | +$31.9K | ﹤0.01% | 3644 |
|
|
2013
Q2 | $86K | Buy |
+24,010
| New | +$86K | ﹤0.01% | 3645 |
|